These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21688257)

  • 1. An enzymatic assay for detection of viral entry.
    Tscherne DM; García-Sastre A
    Curr Protoc Cell Biol; 2011 Jun; Chapter 26():Unit 26.12. PubMed ID: 21688257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzymatic virus-like particle assay for sensitive detection of virus entry.
    Tscherne DM; Manicassamy B; García-Sastre A
    J Virol Methods; 2010 Feb; 163(2):336-43. PubMed ID: 19879300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
    Xiao JH; Rijal P; Schimanski L; Tharkeshwar AK; Wright E; Annaert W; Townsend A
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics.
    Wolf MC; Wang Y; Freiberg AN; Aguilar HC; Holbrook MR; Lee B
    Virol J; 2009 Jul; 6():119. PubMed ID: 19646266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cell-cell fusion mediated by Ebola virus glycoproteins.
    Bär S; Takada A; Kawaoka Y; Alizon M
    J Virol; 2006 Mar; 80(6):2815-22. PubMed ID: 16501090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
    Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
    Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
    Kim M; Kim SY; Lee HW; Shin JS; Kim P; Jung YS; Jeong HS; Hyun JK; Lee CK
    Antiviral Res; 2013 Nov; 100(2):460-72. PubMed ID: 23954192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
    Chlanda P; Schraidt O; Kummer S; Riches J; Oberwinkler H; Prinz S; Kräusslich HG; Briggs JA
    J Virol; 2015 Sep; 89(17):8957-66. PubMed ID: 26085153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
    Chen BJ; Leser GP; Morita E; Lamb RA
    J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
    Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
    J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.
    Marzi A; Wegele A; Pöhlmann S
    Virology; 2006 Sep; 352(2):345-56. PubMed ID: 16777170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms.
    Jones DM; Padilla-Parra S
    Sensors (Basel); 2016 Jun; 16(7):. PubMed ID: 27347948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A luciferase-based budding assay for Ebola virus.
    McCarthy SE; Licata JM; Harty RN
    J Virol Methods; 2006 Oct; 137(1):115-9. PubMed ID: 16837071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entry of Ebola Virus is an Asynchronous Process.
    Reynard O; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S199-203. PubMed ID: 25941332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.
    Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ching-fang-pai-tu-san inhibits the release of influenza virus.
    Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
    J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins.
    Leser GP; Lamb RA
    Virology; 2005 Nov; 342(2):215-27. PubMed ID: 16249012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.